20-5301913-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_144773.4(PROKR2):c.*127T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.743 in 800,984 control chromosomes in the GnomAD database, including 221,746 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.73 ( 40456 hom., cov: 32)
Exomes 𝑓: 0.75 ( 181290 hom. )
Consequence
PROKR2
NM_144773.4 3_prime_UTR
NM_144773.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.362
Genes affected
PROKR2 (HGNC:15836): (prokineticin receptor 2) Prokineticins are secreted proteins that can promote angiogenesis and induce strong gastrointestinal smooth muscle contraction. The protein encoded by this gene is an integral membrane protein and G protein-coupled receptor for prokineticins. The encoded protein is similar in sequence to GPR73, another G protein-coupled receptor for prokineticins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 20-5301913-A-G is Benign according to our data. Variant chr20-5301913-A-G is described in ClinVar as [Benign]. Clinvar id is 1232229.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.75 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROKR2 | NM_144773.4 | c.*127T>C | 3_prime_UTR_variant | 3/3 | ENST00000678254.1 | NP_658986.1 | ||
PROKR2 | XM_017027646.2 | c.*127T>C | 3_prime_UTR_variant | 3/4 | XP_016883135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROKR2 | ENST00000678254.1 | c.*127T>C | 3_prime_UTR_variant | 3/3 | NM_144773.4 | ENSP00000504128 | P1 | |||
PROKR2 | ENST00000217270.4 | c.*127T>C | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000217270 | P1 | |||
PROKR2 | ENST00000678059.1 | c.*127T>C | 3_prime_UTR_variant | 3/3 | ENSP00000503366 |
Frequencies
GnomAD3 genomes AF: 0.729 AC: 110847AN: 152026Hom.: 40412 Cov.: 32
GnomAD3 genomes
AF:
AC:
110847
AN:
152026
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.746 AC: 484230AN: 648840Hom.: 181290 AF XY: 0.748 AC XY: 249837AN XY: 333788
GnomAD4 exome
AF:
AC:
484230
AN:
648840
Hom.:
AF XY:
AC XY:
249837
AN XY:
333788
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.729 AC: 110941AN: 152144Hom.: 40456 Cov.: 32 AF XY: 0.731 AC XY: 54361AN XY: 74384
GnomAD4 genome
AF:
AC:
110941
AN:
152144
Hom.:
Cov.:
32
AF XY:
AC XY:
54361
AN XY:
74384
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2414
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at